Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Expanded Access to 11C Choline PET/CT and 11C Choline PET/MR for Staging of Recurrent Prostate Cancer With Comparison Study of CT and MR Modalities

NCT02260817 is registered in ClinicalTrials.gov with Global Isotopes, LLC d/b/a Zevacor Molecular as lead sponsor.

NCT NCT02260817
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02260817 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Expanded Access to 11C Choline PET/CT and 11C Choline PET/MR for Staging of Recurrent Prostate Cancer With Comparison Study of CT and MR Modalities
Lead sponsor
Global Isotopes, LLC d/b/a Zevacor Molecular
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2014
Completion date
June 30, 2018
Enrollment
109 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic prostate cancer